---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-063396"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T12:22:12.335118+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Collegium shareholders re-elect all eight directors and approve say-on-pay at 2024 annual meeting

## Summary
- All eight director nominees re-elected; each received >98% of votes cast (For range: 25.4M-28.4M).
- Advisory vote on executive compensation passed with 28,311,783 For (98.8% of votes cast).
- Ratification of Deloitte & Touche as independent auditor for FY2024 approved with 30,106,217 For.
- Annual meeting held May 16, 2024; 31,059,529 shares present (94.9% of outstanding shares).
- Broker non-votes were 2,360,841 on director and say-on-pay; 837,061 on auditor ratification.

## SEC filing metadata
- accession: 0001104659-24-063396
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465924063396/0001104659-24-063396-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465924063396/tm2414882d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-063396
- JSON: https://secwatch.observer/filing/0001104659-24-063396.json
- Plain text: https://secwatch.observer/filing/0001104659-24-063396.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.